David Cameron

发表

Mature results of a randomized phase II multicenter study of exemestane versus tamoxifen as first-line hormone therapy for postmenopausal women with metastatic breast cancer.

M. Piccart, M. Nooij, R. Paridaens, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.